italyit
When will corona be a beer again?

When will corona be a beer again?

16-04-2021 | Graph of the week

Not so very long ago, corona was first and foremost a popular and refreshing Mexican beer. But for more than a year, we have been living with the virus and the disease, with large parts of the world still dealing with the resulting lockdowns and inundated hospitals. Fortunately, there’s light at the end of the tunnel: we have started vaccinating people. How are the different developed and emerging countries doing?

  • Jaap  van der Hart
    Jaap
    van der Hart
    Equity Fund Manager
Source: Our World in Data

Israel is leading the way, with more than 60% of the population having been vaccinated, and life for those who have had shots is more or less back to normal. Images of jubilant people filling terraces in Tel Aviv have featured frequently in the news recently. Things are also going well in the US and the UK, both of which started their vaccination program relatively early. EU countries are lagging behind, with a current vaccination rate of 16%, yet the pace of vaccinations is now on par.

In emerging countries, vaccination rates and the pace of vaccinations are significantly lower in most cases. Two exceptions are Hungary and Chile. Both countries have a relatively high infection rate, but at the same time have been quick to procure vaccines. Hungary has also procured Russian Sputnik and Chinese Sinopharm vaccines, against EU policy.

And then there are countries where the vaccination rate is still low, but the disease has remained under control. This is true for China, Japan, South Korea and Taiwan. There is less urgency to act fast in these countries, despite this meaning they will need to remain vigilant for longer.

Graph of the week
If a picture is worth 1,000 words, a chart can say it all. Our Graph of the Week gives the top picks from the Robeco Investment Solutions team.
Graph of the week
Overview

Concerns about India and Brazil

But there are also countries where things are going less well. First up is India, a big producer and exporter of vaccines, which has administered more than 100 million vaccine doses. Relative to the total population, however, this is just 7%, while the number of new infections is soaring. The vaccinations are not coming soon enough and lockdowns to curb the new wave seem inevitable, although not everyone seems of aware of the danger considering the recent images of religious festivals. 

Second is Brazil, the country where President Bolsonaro systematically plays down the disease and where there is little to no national prevention policy in place. The virus has hit hard, with high infection and death rates. In terms of vaccinations, Brazil is doing a little better than some other emerging countries, but the policy response has been inadequate there too, as the country has put too much focus on AstraZeneca, and missed other options. Given the severity of the disease, more vaccinations are desperately needed. 

Other emerging countries have shown a mixed picture but, with a few exceptions, are lagging behind the Western world in the roll-out of vaccines. A resurgence of virus infections remains a risk, also for countries where the infection rate is currently relatively low.

In the West, we hope to have vaccinated enough people by the summer to start returning to normal life. Large Asian countries such as Japan, China and Korea are lagging behind in terms of vaccinations, but Covid-19 is much better under control there. Vaccinations are being administered in the rest of the world too, but at a much slower pace. And in several countries, new infections are still high. 

So, while pavement cafés in some countries will be allowed to reopen soon, corona will primarily remain a serious and impactful disease for a large part of the global population this year.

Gli argomenti collegati a questo articolo sono:
Logo

Disclaimer

Confermo di essere un cliente professionale

Le informazioni e le opinioni contenute in questa sezione del Sito cui sta accedendo sono destinate esclusivamente a Clienti Professionali come definiti dal Regolamento Consob n. 16190 del 29 ottobre 2007 (articolo 26 e Allegato 3) e dalla Direttiva CE n. 2004/39 (Allegato II), e sono concepite ad uso esclusivo di tali categorie di soggetti. Ne è vietata la divulgazione, anche solo parziale.

Al fine di accedere a tale sezione riservata, si prega di confermare di essere un  Cliente Professionale, declinando Robeco qualsivoglia responsabilità in caso di accesso effettuato da una persona che non sia un cliente professionale.

In ogni caso, le informazioni e le opinioni ivi contenute non costituiscono un'offerta o una sollecitazione all'investimento e non costituiscono una raccomandazione o consiglio, anche di carattere fiscale, o un'offerta, finalizzate all'investimento, e non devono in alcun caso essere interpretate come tali.

Prima di  ogni investimento, per una descrizione dettagliata delle caratteristiche, dei rischi e degli oneri connessi, si raccomanda di esaminare il Prospetto, i KIIDs delle classi autorizzate per la commercializzazione in Italia, la relazione annuale o semestrale e lo Statuto, disponibili sul presente Sito o presso i collocatori.
L’investimento in prodotti finanziari è soggetto a fluttuazioni, con conseguente variazione al rialzo o al ribasso dei prezzi, ed è possibile che non si riesca a recuperare l'importo originariamente investito.

Rifiuto